- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Src Antibody DCI-19 / SRC Rabbit Monoclonal Antibody targets SRC, a non-receptor tyrosine kinase and founding member of the Src family of protein kinases. Also known as c-Src and proto-oncogene tyrosine-protein kinase Src, this protein regulates intracellular signaling pathways involved in cell proliferation, adhesion, migration, differentiation, and survival. SRC functions downstream of numerous cell surface receptors, including receptor tyrosine kinases, integrins, and G protein-coupled receptors. By phosphorylating specific tyrosine residues on signaling proteins, SRC coordinates responses to extracellular stimuli and contributes to the regulation of cytoskeletal organization and cellular behavior.
SRC contains several conserved structural regions, including an N-terminal membrane-targeting domain, SH3 and SH2 interaction domains, a catalytic SH1 kinase domain, and a C-terminal regulatory tail. Myristoylation promotes association with cellular membranes, positioning SRC near receptors and signaling complexes. Its activity is tightly regulated through phosphorylation and intramolecular interactions. Phosphorylation of the C-terminal inhibitory tyrosine residue by C-terminal Src kinase (CSK) stabilizes an inactive conformation, while dephosphorylation and conformational changes promote kinase activation. Autophosphorylation within the activation loop further enhances catalytic activity.
Activated SRC participates in signaling networks that regulate focal adhesion turnover, actin remodeling, and cell movement. Interactions with focal adhesion kinase (FAK), paxillin, and other adhesion-associated proteins connect SRC activity to integrin signaling and cellular responses to the extracellular matrix. SRC also influences the RAS-MAPK, PI3K-AKT, and STAT signaling pathways, linking receptor activation to transcriptional regulation, metabolism, and survival. These interactions allow SRC to integrate multiple signaling inputs and coordinate processes such as epithelial organization, cell polarity, and tissue remodeling.
Dysregulated SRC signaling has been implicated in cancer progression, particularly through its effects on proliferation, migration, invasion, and resistance to apoptosis. Elevated SRC activity has been investigated in colorectal, breast, lung, and other malignancies, where it can cooperate with growth factor receptors and oncogenic signaling pathways. SRC also participates in normal developmental processes and cellular responses to mechanical and biochemical signals. Its regulatory interactions and extensive substrate network make it an important target for studying tyrosine kinase signaling. Src Antibody DCI-19 supports investigation of SRC expression and its contributions to adhesion-dependent signaling, cytoskeletal regulation, and cancer-associated cellular behavior.
For additional validation of SRC expression across human and rodent samples, including knockout-controlled Western blot analysis, see our Src Antibody III-19.
Optimal dilution of the Src Antibody DCI-19 / SRC Rabbit Monoclonal Antibody should be determined by the researcher.
A synthetic peptide specific to human Src was used as the immunogen for the Src antibody.
Store the Src antibody at -20oC.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.